Senhwa Biosciences’ Pidnarulex joins forces with global PD-1 leaders to advance next-gen immunotherapy
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
Prior to this appointment, he served as Vice-Chancellor of Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur,
The discussions are expected to pave the way for the creation of a consolidated national knowledge-sharing platform on IT-enabled Ayush services,
The study further confirmed that GAL-101 effectively crosses the blood-brain barrier
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Drug Hunter is already relied upon by researchers at more than 200 leading organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, Deerfield Management
Subscribe To Our Newsletter & Stay Updated